TrialCardiovascular diabetology2013

Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200-500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study.

Eliot A Brinton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.